Translational Cancer Research 期刊简介
Translational Cancer Research (Transl Cancer Res TCR; Print ISSN: 2218-676X; Online ISSN 2219-6803; http://tcr.amegroups.com/) is an Open Access, peer-reviewed journal, indexed in Science Citation Index Expanded (SCIE). TCR publishes laboratory studies of novel therapeutic interventions as well as clinical trials which evaluate new treatment paradigms for cancer; results of novel research investigations which bridge the laboratory and clinical settings including risk assessment, cellular and molecular characterization, prevention, detection, diagnosis and treatment of human cancers with the overall goal of improving the clinical care of cancer patients. The focus of TCR is original, peer-reviewed, science-based research that successfully advances clinical medicine toward the goal of improving patients' quality of life. The editors and an international advisory group of scientists and clinician-scientists as well as other experts will hold TCR articles to the high-quality standards. We accept Original Articles as well as Review Articles, Editorials and Brief Articles.
转化癌症研究 (Transl Cancer Res TCR; 打印ISSN: 2218-676X; 在线ISSN 2219-6803; http://tcr.amegroups.com/) 是一本开放获取的同行评审期刊，在科学引文索引扩展 (SCIE) 中索引。TCR发表了新的治疗干预措施的实验室研究以及评估癌症新治疗范例的临床试验; 连接实验室和临床环境的新研究结果，包括风险评估，细胞和分子表征，预防，检测，人类癌症的诊断和治疗，以提高癌症患者的临床护理为总体目标。TCR的重点是原创的，同行评审的，基于科学的研究，成功地将临床医学推向了改善患者生活质量的目标。编辑和一个由科学家和临床医生组成的国际咨询小组-科学家以及其他专家将持有符合高质量标准的TCR文章。我们接受原创文章以及评论文章、社论和简短文章。
|
期刊ISSN
|
2218-676X |
|
影响指数
|
1.229 |
|
最新CiteScore值
|
0.70 查看CiteScore评价数据 |
|
最新自引率
|
11.00% |
|
官方指定润色网址
|
https://www.deeredit.com/?type=ss1 |
|
投稿语言要求
|
Improve the quality of the paper, eliminate grammar and spelling errors, increase readability, ensure accurate communication of viewpoints, enhance academic reputation, and increase the chances of the paper being accepted. 建议点击这个网址：https://www.deeredit.com/?type=ss2，资深审稿专家为您评估稿件质量，提供针对性改进建议，最终可助您极大提升目标期刊录用率 |
|
期刊官方网址
hot |
https://www.peipusci.com/?type=9 |
|
杂志社征稿网址
hot |
https://www.peipusci.com/?type=10 |
|
通讯地址
|
FLAT-RM C 16F, KINGS WING PLAZA 1, NO 3 KWAN ST, SHATIN, PEOPLES R CHINA, HONG KONG, 00000 |
|
偏重的研究方向（学科）
|
ONCOLOGY- |
|
出版周期
|
|
|
出版年份
|
0 |
|
出版国家/地区
|
PEOPLES R CHINA |
|
是否OA
|
No |
|
SCI期刊coverage
|
Science Citation Index Expanded（科学引文索引扩展） |
|
NCBI查询
|
PubMed Central (PMC)链接 全文检索(pubmed central) |
|
最新中科院JCR分区
|
大类(学科)
小类(学科)
综述期刊
医学
ONCOLOGY(肿瘤学)4区
否
|
|||||
|
最新的影响因子
|
1.229 | |||||
| 最新公布的期刊年发文量 |
|
|||||
| 总被引频次 | 22 | |||||
| 影响因子趋势图 |
近年的影响因子趋势图（整体平稳趋势）
|
|||||
2022年预警名单预测最新
|
最新CiteScore值
|
0.70
|
||||||||||||||||||
| 年文章数 | 776 | ||||||||||||||||||
|
SJR
|
0.254 | ||||||||||||||||||
|
SNIP
|
0.253 | ||||||||||||||||||
|
CiteScore排名
|
|
||||||||||||||||||
| CiteScore趋势图 |
CiteScore趋势图
|
||||||||||||||||||
|
本刊同领域相关期刊
|
|
| 期刊名称 | IF值 |
| INTEGRATIVE CANCER THERAPIES | 3.246 |
| Hormones & Cancer | 3.83 |
| ENDOCRINE-RELATED CANCER | 5.621 |
| Frontiers of Medicine | 4.546 |
| Molecular Medicine Reports | 2.922 |
| Molecular Therapy-Oncolytics | 7.128 |
| American Journal of Translational Research | 4.019 |
| BREAST | 4.336 |
| Breast Care | 2.831 |
|
本刊同分区等级的相关期刊
|
|
| 期刊名称 | IF值 |
| Molecular Medicine Reports | 2.922 |
| Breast Care | 2.831 |
| Breast Cancer | 4.197 |
| Breast Journal | 2.407 |
| EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY | 0.194 |
| INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 3.403 |
| INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS | 2.632 |
| Onkologe | 0.232 |
| NEOPLASMA | 2.549 |
| 分享者 | 点评内容 |
